GlassScriptPhysician profile
Christine C Pierre
NPI 1548418700
$8,138.29
in general payments reported to CMS, 2019-2025
52 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,561 · 2020: $2,533 · 2021: $1,976 · 2022: $90.83 · 2023: $108 · 2024: $438 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.99 |
| Education | $230.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $750.69 | 2019-2023 | |
| Amgen INC. | $531.75 | 2019-2025 | Uplizna |
| Allergan, INC. | $505.64 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $463.64 | 2019-2025 | Ultomiris |
| Adamas Pharmaceuticals, INC. | $442.86 | 2019-2021 | |
| Emd Serono, INC. | $413.58 | 2019-2021 | |
| Ucb, INC. | $407.16 | 2019-2025 | Fintepla |
| Eisai INC. | $402.25 | 2019-2024 | |
| Genzyme Corporation | $357.89 | 2019-2022 | |
| Biogen, INC. | $324.55 | 2019-2022 | |
| Abbvie INC. | $307.80 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $295.00 | 2019-2025 | Austedo Xr |
| Genentech USA, INC. | $275.51 | 2019-2024 | Ocrevus, Ocrevus Zunovo |
| Sk Life Science, INC. | $244.71 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $234.90 | 2019-2021 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Pierre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.